|
Alburquerque-Gonzalez B, Montoro-Garcia S, Bernabe-Garcia A, Bernabe-Garcia M, Campioni-Rodrigues P, Rodriguez-Martinez A, Luque I, Salo T, Perez-Garrido A, Perez-Sanchez H, Cayuela ML, Luengo-Gil G, Luchinat E, Postigo-Corrales F, Staderini T, Nicolas FJ, Conesa-Zamora P. Monastrol suppresses invasion and metastasis in human colorectal cancer cells by targeting fascin independent of kinesin-Eg5 pathway. Biomed Pharmacother. 2024 Jun;175:116785. doi: 10.1016/j.biopha.2024.116785. Epub 2024 May 22. Erratum In: Biomed Pharmacother. 2024 Oct;179:117411. doi: 10.1016/j.biopha.2024.117411. PubMed PMID: 38781869.
AÑO: 2024; IF: 7.5
|
38781869
|
Rodriguez-Martinez A, Giraldo-Ruiz L, Ramos MC, Luque I, Ribeiro D, Postigo-Corrales F, Alburquerque-Gonzalez B, Montoro-Garcia S, Arroyo-Rodriguez AB, Conesa-Zamora P, Hurtado AM, Luengo-Gil G, Perez-Sanchez H. Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer. Sci Rep. 2025 Apr 28;15(1):14906. doi: 10.1038/s41598-025-96457-x. PubMed PMID: 40295602; PubMed Central PMCID: PMC12037858.
AÑO: 2025; IF: 3.9
|
|
Postigo-Corrales F, Beltran-Videla A, Lazaro-Sanchez AD, Hurtado AM, Conesa-Zamora P, Arroyo AB, Luengo-Gil G. Docetaxel Resistance in Breast Cancer: Current Insights and Future Directions. Int J Mol Sci. 2025 Jul 23;26(15):7119. doi: 10.3390/ijms26157119. PubMed PMID: 40806254.
AÑO: 2025; IF: 4.9
|
|
Perez-Parra D, Postigo-Corrales F, Cruz Santos AF, Sanchez-Espinosa A, Acosta-Ortega J, Carrillo-Vicente R, Lopez-Abellan MD, Conesa-Zamora P, Luengo-Gil G, Hurtado-Lopez AM. Characterization and Prognostic Impact of Fascin Expression in the Tumor Microenvironment of Triple-Negative Breast Cancer: Clues for a Tailored Therapy. Lab Invest. 2025 Nov 28:104268. doi: 10.1016/j.labinv.2025.104268. Online ahead of print. PubMed PMID: 41319754.
AÑO: 2025; IF: 4.2
|